Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for DVAX

Stock Name	Dynavax Technologies Corporation
Ticker	DVAX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US2681582019
LEI	549300T5URIXWDILX594

Show aggregate DVAX holdings

News associated with DVAX

Dynavax Technologies (NASDAQ:DVAX) Receives “Market Outperform” Rating from JMP Securities: JMP Securities reissued their market outperform rating on shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) in a research report sent to investors on Friday,Benzinga reports. The brokerage currently has a $32.00 price target on the biopharmaceutical company’s stock. Separately, Wall Street Zen upgraded shares of Dynavax Technologies from a “hold” rating to a “buy” […] - 2025-08-25 02:58:58
Natixis Advisors LLC Grows Holdings in Dynavax Technologies Corporation (NASDAQ:DVAX): Natixis Advisors LLC boosted its position in shares of Dynavax Technologies Corporation (NASDAQ:DVAX – Free Report) by 16.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 26,314 shares of the biopharmaceutical company’s stock after purchasing an additional 3,778 shares during the period. Natixis Advisors LLC’s holdings in Dynavax Technologies were worth $341,000 as of […] - 2025-08-13 04:30:57
Dynavax Technologies (NASDAQ:DVAX) Raised to Buy at Wall Street Zen: Wall Street Zen upgraded shares of Dynavax Technologies (NASDAQ:DVAX – Free Report) from a hold rating to a buy rating in a research note published on Saturday morning. Other equities research analysts have also recently issued research reports about the stock. JMP Securities raised their price objective on shares of Dynavax Technologies from $31.00 to […] - 2025-08-12 03:10:58
DekaBank Deutsche Girozentrale Purchases Shares of 2,260 Dynavax Technologies Corporation (NASDAQ:DVAX): DekaBank Deutsche Girozentrale purchased a new stake in Dynavax Technologies Corporation (NASDAQ:DVAX – Free Report) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 2,260 shares of the biopharmaceutical company’s stock, valued at approximately $30,000. A number of other hedge funds and other […] - 2025-07-15 06:34:54
After Hours Most Active for Jul 11, 2025 : HPE, AAPL, ABVE, INTC, CMCSA, NVDA, DVAX, PFE, WMB, LION, KO, JBS: The NASDAQ 100 After Hours Indicator is down -9.83 to 22,770.77. The total After hours volume is currently 110,913,091 shares traded.The following are the most active stocks for the after hours session: Hewlett Packard Enterprise Company (HPE) is unchanged at $20.72, with 5,619, - 2025-07-11 17:24:56
GAMMA Investing LLC Increases Stock Holdings in Dynavax Technologies Corporation (NASDAQ:DVAX): GAMMA Investing LLC boosted its position in shares of Dynavax Technologies Corporation (NASDAQ:DVAX – Free Report) by 88.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,729 shares of the biopharmaceutical company’s stock after acquiring an additional 3,627 shares during the quarter. GAMMA […] - 2025-07-07 04:15:20
Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Sold by Illinois Municipal Retirement Fund: Illinois Municipal Retirement Fund trimmed its position in Dynavax Technologies Corporation (NASDAQ:DVAX – Free Report) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 61,420 shares of the biopharmaceutical company’s stock after selling 3,143 shares during the period. Illinois Municipal […] - 2025-07-03 05:11:01
How The Parts Add Up: VIOO Headed For $118: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-23 08:46:06
Exchange Traded Concepts LLC Cuts Stock Position in Dynavax Technologies Corporation (NASDAQ:DVAX): Exchange Traded Concepts LLC lessened its holdings in Dynavax Technologies Corporation (NASDAQ:DVAX – Free Report) by 21.3% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 128,078 shares of the biopharmaceutical company’s stock after selling 34,648 shares during the period. Exchange Traded Concepts LLC owned 0.10% of […] - 2025-06-18 04:58:52
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 113,872 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 37.2% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 420,325 shares of the biopharmaceutical company’s stock after purchasing an additional 113,872 shares during the quarter. UBS AM a distinct […] - 2025-06-03 05:13:11
Millennium Management LLC Has $2.33 Million Holdings in Dynavax Technologies Co. (NASDAQ:DVAX): Millennium Management LLC cut its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 87.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 182,241 shares of the biopharmaceutical company’s stock after selling 1,300,711 shares during the […] - 2025-06-02 04:48:57
Two Sigma Advisers LP Sells 30,600 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Two Sigma Advisers LP reduced its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 18.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 134,518 shares of the biopharmaceutical company’s stock after selling 30,600 shares during the period. Two Sigma Advisers LP’s holdings in Dynavax Technologies were worth $1,718,000 at the […] - 2025-05-30 05:30:54
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Position in Dynavax Technologies Co. (NASDAQ:DVAX): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,796 shares of the biopharmaceutical company’s stock after buying an additional 2,206 […] - 2025-05-26 04:38:52
Gotham Asset Management LLC Decreases Position in Dynavax Technologies Co. (NASDAQ:DVAX): Gotham Asset Management LLC lessened its holdings in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 30.4% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,066 shares of the biopharmaceutical company’s stock after selling 6,149 shares during the period. Gotham Asset Management LLC’s […] - 2025-05-22 05:34:50
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by The Manufacturers Life Insurance Company: The Manufacturers Life Insurance Company cut its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 3.1% in the 4th quarter, Holdings Channel.com reports. The firm owned 64,711 shares of the biopharmaceutical company’s stock after selling 2,045 shares during the period. The Manufacturers Life Insurance Company’s holdings in Dynavax Technologies were worth […] - 2025-05-15 04:45:07
Comerica Bank Has $759,000 Stake in Dynavax Technologies Co. (NASDAQ:DVAX): Comerica Bank lifted its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 62.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,412 shares of the biopharmaceutical company’s stock after purchasing an additional 22,831 shares during the quarter. Comerica Bank’s holdings […] - 2025-05-14 05:54:56
66,354 Shares in Dynavax Technologies Co. (NASDAQ:DVAX) Bought by First Trust Advisors LP: First Trust Advisors LP purchased a new stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm purchased 66,354 shares of the biopharmaceutical company’s stock, valued at approximately $847,000. Several other hedge funds also recently modified their holdings of the stock. Barclays PLC grew its […] - 2025-05-09 05:28:49
Dynavax Technologies (NASDAQ:DVAX) Shares Down 9.2% After Earnings Miss: Dynavax Technologies Co. (NASDAQ:DVAX – Get Free Report) shares were down 9.2% during mid-day trading on Wednesday after the company announced weaker than expected quarterly earnings. The company traded as low as $10.12 and last traded at $9.92. Approximately 479,048 shares changed hands during mid-day trading, a decline of 79% from the average daily volume […] - 2025-05-09 02:40:49
Envestnet Asset Management Inc. Purchases 2,796 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Envestnet Asset Management Inc. lifted its position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 20.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 16,162 shares of the biopharmaceutical company’s stock after acquiring an additional 2,796 shares during the period. Envestnet Asset Management Inc.’s […] - 2025-05-08 04:49:01
Head to Head Survey: Dynavax Technologies (NASDAQ:DVAX) and Lotus Pharmaceuticals (OTCMKTS:LTUS): Dynavax Technologies (NASDAQ:DVAX – Get Free Report) and Lotus Pharmaceuticals (OTCMKTS:LTUS – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, institutional ownership, dividends, valuation and risk. Profitability This table compares Dynavax Technologies and […] - 2025-04-29 03:12:48
Invesco Ltd. Sells 58,864 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Invesco Ltd. cut its holdings in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 3.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,649,585 shares of the biopharmaceutical company’s stock after selling 58,864 shares during the quarter. Invesco Ltd.’s holdings in […] - 2025-04-20 05:22:48
Franklin Resources Inc. Purchases 4,260 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Franklin Resources Inc. boosted its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 5.2% during the fourth quarter, Holdings Channel reports. The institutional investor owned 86,675 shares of the biopharmaceutical company’s stock after acquiring an additional 4,260 shares during the quarter. Franklin Resources Inc.’s holdings in Dynavax Technologies were worth $1,107,000 […] - 2025-04-16 04:36:48
Wellington Management Group LLP Sells 8,247 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Wellington Management Group LLP lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 12.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 59,777 shares of the biopharmaceutical company’s stock after selling 8,247 shares during the period. Wellington Management Group LLP’s holdings in […] - 2025-04-15 05:18:53
Norges Bank Acquires New Stake in Dynavax Technologies Co. (NASDAQ:DVAX): Norges Bank acquired a new stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 607,800 shares of the biopharmaceutical company’s stock, valued at approximately $7,762,000. A number of other large […] - 2025-04-09 05:30:54
Teacher Retirement System of Texas Boosts Stock Holdings in Dynavax Technologies Co. (NASDAQ:DVAX): Teacher Retirement System of Texas lifted its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 12.2% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 34,979 shares of the biopharmaceutical company’s stock after acquiring an additional 3,797 shares during the quarter. Teacher Retirement System of Texas’ holdings in Dynavax Technologies […] - 2025-04-01 05:18:46
Thrivent Financial for Lutherans Lowers Position in Dynavax Technologies Co. (NASDAQ:DVAX): Thrivent Financial for Lutherans trimmed its holdings in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 1.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 94,496 shares of the biopharmaceutical company’s stock after selling 1,208 shares during the quarter. Thrivent Financial for […] - 2025-04-01 04:38:48
12,328 Shares in Dynavax Technologies Co. (NASDAQ:DVAX) Acquired by Cibc World Markets Corp: Cibc World Markets Corp acquired a new position in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 12,328 shares of the biopharmaceutical company’s stock, valued at approximately $157,000. A number of other institutional investors also […] - 2025-03-28 06:18:45
Dynavax Technologies Co. (NASDAQ:DVAX) Shares Sold by PNC Financial Services Group Inc.: PNC Financial Services Group Inc. lessened its stake in shares of Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 8.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 9,122 shares of the biopharmaceutical company’s stock after selling 891 shares during the […] - 2025-03-25 06:08:49
Wealthfront Advisers LLC Makes New Investment in Dynavax Technologies Co. (NASDAQ:DVAX): Wealthfront Advisers LLC purchased a new position in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 15,136 shares of the biopharmaceutical company’s stock, valued at approximately $193,000. A number of other institutional investors and hedge […] - 2025-03-18 06:26:51
Smartleaf Asset Management LLC Buys 2,034 Shares of Dynavax Technologies Co. (NASDAQ:DVAX): Smartleaf Asset Management LLC lifted its stake in Dynavax Technologies Co. (NASDAQ:DVAX – Free Report) by 463.3% during the 4th quarter, Holdings Channel reports. The firm owned 2,473 shares of the biopharmaceutical company’s stock after acquiring an additional 2,034 shares during the period. Smartleaf Asset Management LLC’s holdings in Dynavax Technologies were worth $32,000 at […] - 2025-03-13 05:54:48

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) DVAX holdings

Date	Number of DVAX Shares Held	Base Market Value of DVAX Shares	Local Market Value of DVAX Shares	Change in DVAX Shares Held	Change in DVAX Base Value	Current Price per DVAX Share Held	Previous Price per DVAX Share Held
2025-12-03 (Wednesday)	81,555	USD 894,658	USD 894,658	0	USD 7,340	USD 10.97	USD 10.88
2025-12-02 (Tuesday)	81,555	USD 887,318	USD 887,318	2,925	USD 45,191	USD 10.88	USD 10.71
2025-12-01 (Monday)	78,630	USD 842,127	USD 842,127	0	USD -51,896	USD 10.71	USD 11.37
2025-11-28 (Friday)	78,630	USD 894,023	USD 894,023	195	USD -2,489	USD 11.37	USD 11.43
2025-11-27 (Thursday)	78,435	USD 896,512	USD 896,512	0	USD 0	USD 11.43	USD 11.43
2025-11-26 (Wednesday)	78,435	USD 896,512	USD 896,512	585	USD 3,572	USD 11.43	USD 11.47
2025-11-25 (Tuesday)	77,850	USD 892,940	USD 892,940	975	USD 13,490	USD 11.47	USD 11.44
2025-11-24 (Monday)	76,875	USD 879,450	USD 879,450	195	USD 22,168	USD 11.44	USD 11.18
2025-11-21 (Friday)	76,680	USD 857,282	USD 857,282	0	USD 29,138	USD 11.18	USD 10.8
2025-11-20 (Thursday)	76,680	USD 828,144	USD 828,144	-780	USD -27,789	USD 10.8	USD 11.05
2025-11-19 (Wednesday)	77,460	USD 855,933	USD 855,933	194	USD -11,764	USD 11.05	USD 11.23
2025-11-18 (Tuesday)	77,266	USD 867,697	USD 867,697	1,164	USD 19,921	USD 11.23	USD 11.14
2025-11-17 (Monday)	76,102	USD 847,776	USD 847,776	388	USD 10,379	USD 11.14	USD 11.06

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of DVAX by Blackrock for IE00BYXG2H39

Show aggregate share trades of DVAX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 2,925 10.920 10.655 10.681 USD 31,243 11.48
2025-11-28 BUY 195 11.490 11.340 11.355 USD 2,214 11.48
2025-11-26 BUY 585 11.525 11.330 11.349 USD 6,639 11.48
2025-11-26 BUY 585 11.525 11.330 11.349 USD 6,639 11.48
2025-11-25 BUY 975 11.580 11.350 11.373 USD 11,089 11.48
2025-11-24 BUY 195 11.500 11.170 11.203 USD 2,185 11.48
2025-11-20 SELL -780 11.260 10.760 10.810 USD -8,432 11.49 Profit of 528 on sale
2025-11-19 BUY 194 11.240 10.910 10.943 USD 2,123 11.49
2025-11-18 BUY 1,164 11.270 11.040 11.063 USD 12,877 11.49
2025-11-17 BUY 388 11.290 11.020 11.047 USD 4,286 11.49
2025-11-14 BUY 194 11.240 11.025 11.046 USD 2,143 11.49
2025-11-12 BUY 194 11.430 11.155 11.182 USD 2,169 11.50
2025-11-10 BUY 194 11.235 10.860 10.897 USD 2,114 11.50
2025-11-06 BUY 194 11.240 10.510 10.583 USD 2,053 11.51
2025-11-04 BUY 195 10.315 10.040 10.067 USD 1,963 11.52
2025-10-30 BUY 975 10.460 10.110 10.145 USD 9,891 11.54
2025-10-29 BUY 390 10.300 10.580 10.552 USD 4,115 11.55
2025-10-22 SELL -776 10.150 10.220 10.213 USD -7,925 11.58 Profit of 1,060 on sale
2025-10-20 BUY 388 10.070 10.120 10.115 USD 3,925 11.60
2025-10-17 BUY 969 9.830 9.930 9.920 USD 9,612 11.61
2025-10-15 BUY 1,544 9.930 9.980 9.975 USD 15,401 11.61
2025-10-03 BUY 1,365 10.100 10.180 10.172 USD 13,885 11.63
2025-10-02 BUY 195 10.100 10.340 10.316 USD 2,012 11.64
2025-09-30 BUY 390 9.930 10.030 10.020 USD 3,908 11.66
2025-09-26 BUY 390 9.780 9.820 9.816 USD 3,828 11.68
2025-09-25 BUY 390 9.730 10.030 10.000 USD 3,900 11.69
2025-09-24 SELL -4,347 9.960 9.990 9.987 USD -43,413 11.70 Profit of 7,459 on sale
2025-09-18 BUY 208 9.750 9.840 9.831 USD 2,045 11.71
2025-09-17 BUY 627 9.570 9.770 9.750 USD 6,113 11.73
2025-08-20 SELL -828 10.420 10.580 10.564 USD -8,747 11.76 Profit of 991 on sale
2025-07-30 BUY 824 11.170 11.410 11.386 USD 9,382 11.80
2025-07-17 SELL -412 10.670 10.780 10.769 USD -4,437 11.84 Profit of 441 on sale
2025-07-11 SELL -1,656 10.580 10.880 10.850 USD -17,968 11.87 Profit of 1,695 on sale
2025-07-07 BUY 621 10.300 10.430 10.417 USD 6,469 11.91
2025-07-02 BUY 11,385 10.160 10.240 10.232 USD 116,491 11.93
2025-06-11 BUY 416 10.180 10.480 10.450 USD 4,347 12.04
2025-06-10 BUY 416 10.430 10.460 10.457 USD 4,350 12.05
2025-06-04 SELL -208 9.890 10.120 10.097 USD -2,100 12.11 Profit of 419 on sale
2025-04-23 BUY 207 10.770 11.190 11.148 USD 2,308 12.68
2025-04-10 SELL -1,656 10.970 11.900 11.807 USD -19,552 12.87 Profit of 1,759 on sale
2025-04-08 SELL -207 11.750 12.810 12.704 USD -2,630 12.89 Profit of 39 on sale
2025-04-07 SELL -207 12.490 12.920 12.877 USD -2,666 12.90 Profit of 4 on sale
2025-04-04 SELL -1,035 12.650 12.870 12.848 USD -13,298 12.90 Profit of 53 on sale
2025-04-01 BUY 860 12.710 12.970 12.944 USD 11,132 12.90
2025-03-31 SELL -621 12.970 13.460 13.411 USD -8,328 12.90 Loss of -317 on sale
2025-03-14 SELL -3,328 13.870 14.010 13.996 USD -46,579 12.77 Loss of -4,084 on sale
2025-03-07 SELL -416 14.400 14.630 14.607 USD -6,077 12.68 Loss of -804 on sale
2025-03-04 SELL -208 13.880 13.990 13.979 USD -2,908 12.61 Loss of -285 on sale
2025-02-25 BUY 416 13.410 13.690 13.662 USD 5,683 12.52
2025-02-19 SELL -208 13.090 13.380 13.351 USD -2,777 12.47 Loss of -184 on sale
2025-02-13 BUY 621 12.690 12.880 12.861 USD 7,987 12.44
2025-02-12 BUY 207 12.450 12.490 12.486 USD 2,585 12.44
2025-02-11 BUY 828 12.700 12.700 12.700 USD 10,516 12.43
2024-12-30 SELL -7,731 12.830 13.050 13.028 USD -100,719 12.19 Loss of -6,448 on sale
2024-11-18 SELL -3,420 11.690 12.360 12.293 USD -42,042 11.74 Loss of -1,893 on sale
2024-11-08 SELL -228 13.010 13.720 13.649 USD -3,112 11.52 Loss of -485 on sale
2024-10-21 SELL -230 10.980 11.100 11.088 USD -2,550 0.00 Loss of -2,550 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	2,925	10.920	10.655	10.681	USD 31,243	11.48
2025-11-28	BUY	195	11.490	11.340	11.355	USD 2,214	11.48
2025-11-26	BUY	585	11.525	11.330	11.349	USD 6,639	11.48
2025-11-26	BUY	585	11.525	11.330	11.349	USD 6,639	11.48
2025-11-25	BUY	975	11.580	11.350	11.373	USD 11,089	11.48
2025-11-24	BUY	195	11.500	11.170	11.203	USD 2,185	11.48
2025-11-20	SELL	-780	11.260	10.760	10.810	USD -8,432	11.49 Profit of 528 on sale
2025-11-19	BUY	194	11.240	10.910	10.943	USD 2,123	11.49
2025-11-18	BUY	1,164	11.270	11.040	11.063	USD 12,877	11.49
2025-11-17	BUY	388	11.290	11.020	11.047	USD 4,286	11.49
2025-11-14	BUY	194	11.240	11.025	11.046	USD 2,143	11.49
2025-11-12	BUY	194	11.430	11.155	11.182	USD 2,169	11.50
2025-11-10	BUY	194	11.235	10.860	10.897	USD 2,114	11.50
2025-11-06	BUY	194	11.240	10.510	10.583	USD 2,053	11.51
2025-11-04	BUY	195	10.315	10.040	10.067	USD 1,963	11.52
2025-10-30	BUY	975	10.460	10.110	10.145	USD 9,891	11.54
2025-10-29	BUY	390	10.300	10.580	10.552	USD 4,115	11.55
2025-10-22	SELL	-776	10.150	10.220	10.213	USD -7,925	11.58 Profit of 1,060 on sale
2025-10-20	BUY	388	10.070	10.120	10.115	USD 3,925	11.60
2025-10-17	BUY	969	9.830	9.930	9.920	USD 9,612	11.61
2025-10-15	BUY	1,544	9.930	9.980	9.975	USD 15,401	11.61
2025-10-03	BUY	1,365	10.100	10.180	10.172	USD 13,885	11.63
2025-10-02	BUY	195	10.100	10.340	10.316	USD 2,012	11.64
2025-09-30	BUY	390	9.930	10.030	10.020	USD 3,908	11.66
2025-09-26	BUY	390	9.780	9.820	9.816	USD 3,828	11.68
2025-09-25	BUY	390	9.730	10.030	10.000	USD 3,900	11.69
2025-09-24	SELL	-4,347	9.960	9.990	9.987	USD -43,413	11.70 Profit of 7,459 on sale
2025-09-18	BUY	208	9.750	9.840	9.831	USD 2,045	11.71
2025-09-17	BUY	627	9.570	9.770	9.750	USD 6,113	11.73
2025-08-20	SELL	-828	10.420	10.580	10.564	USD -8,747	11.76 Profit of 991 on sale
2025-07-30	BUY	824	11.170	11.410	11.386	USD 9,382	11.80
2025-07-17	SELL	-412	10.670	10.780	10.769	USD -4,437	11.84 Profit of 441 on sale
2025-07-11	SELL	-1,656	10.580	10.880	10.850	USD -17,968	11.87 Profit of 1,695 on sale
2025-07-07	BUY	621	10.300	10.430	10.417	USD 6,469	11.91
2025-07-02	BUY	11,385	10.160	10.240	10.232	USD 116,491	11.93
2025-06-11	BUY	416	10.180	10.480	10.450	USD 4,347	12.04
2025-06-10	BUY	416	10.430	10.460	10.457	USD 4,350	12.05
2025-06-04	SELL	-208	9.890	10.120	10.097	USD -2,100	12.11 Profit of 419 on sale
2025-04-23	BUY	207	10.770	11.190	11.148	USD 2,308	12.68
2025-04-10	SELL	-1,656	10.970	11.900	11.807	USD -19,552	12.87 Profit of 1,759 on sale
2025-04-08	SELL	-207	11.750	12.810	12.704	USD -2,630	12.89 Profit of 39 on sale
2025-04-07	SELL	-207	12.490	12.920	12.877	USD -2,666	12.90 Profit of 4 on sale
2025-04-04	SELL	-1,035	12.650	12.870	12.848	USD -13,298	12.90 Profit of 53 on sale
2025-04-01	BUY	860	12.710	12.970	12.944	USD 11,132	12.90
2025-03-31	SELL	-621	12.970	13.460	13.411	USD -8,328	12.90 Loss of -317 on sale
2025-03-14	SELL	-3,328	13.870	14.010	13.996	USD -46,579	12.77 Loss of -4,084 on sale
2025-03-07	SELL	-416	14.400	14.630	14.607	USD -6,077	12.68 Loss of -804 on sale
2025-03-04	SELL	-208	13.880	13.990	13.979	USD -2,908	12.61 Loss of -285 on sale
2025-02-25	BUY	416	13.410	13.690	13.662	USD 5,683	12.52
2025-02-19	SELL	-208	13.090	13.380	13.351	USD -2,777	12.47 Loss of -184 on sale
2025-02-13	BUY	621	12.690	12.880	12.861	USD 7,987	12.44
2025-02-12	BUY	207	12.450	12.490	12.486	USD 2,585	12.44
2025-02-11	BUY	828	12.700	12.700	12.700	USD 10,516	12.43
2024-12-30	SELL	-7,731	12.830	13.050	13.028	USD -100,719	12.19 Loss of -6,448 on sale
2024-11-18	SELL	-3,420	11.690	12.360	12.293	USD -42,042	11.74 Loss of -1,893 on sale
2024-11-08	SELL	-228	13.010	13.720	13.649	USD -3,112	11.52 Loss of -485 on sale
2024-10-21	SELL	-230	10.980	11.100	11.088	USD -2,550	0.00 Loss of -2,550 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of DVAX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	218,185	43	468,109	46.6%
2025-09-18	224,181	1	430,450	52.1%
2025-09-17	320,518	0	599,318	53.5%
2025-09-16	515,585	0	816,810	63.1%
2025-09-15	413,756	510	748,663	55.3%
2025-09-12	443,912	0	704,306	63.0%
2025-09-11	376,507	100	580,069	64.9%
2025-09-10	305,401	0	505,863	60.4%
2025-09-09	276,988	0	476,520	58.1%
2025-09-08	609,864	0	1,769,874	34.5%
2025-09-05	177,442	0	495,061	35.8%
2025-09-04	261,474	0	556,335	47.0%
2025-09-03	398,123	2,650	732,859	54.3%
2025-09-02	383,227	0	786,394	48.7%
2025-08-29	204,456	800	494,881	41.3%
2025-08-28	718,968	0	977,852	73.5%
2025-08-27	431,019	3,824	740,713	58.2%
2025-08-26	301,206	0	714,286	42.2%
2025-08-25	540,934	0	984,209	55.0%
2025-08-22	251,668	0	1,214,364	20.7%
2025-08-21	592,425	1,038	2,175,243	27.2%
2025-08-20	145,944	0	351,793	41.5%
2025-08-19	77,986	4	243,836	32.0%
2025-08-18	138,075	0	260,908	52.9%
2025-08-15	119,222	0	262,831	45.4%
2025-08-14	94,314	0	260,999	36.1%
2025-08-13	286,926	1	753,538	38.1%
2025-08-12	168,061	5,547	436,549	38.5%
2025-08-11	125,712	8,873	621,076	20.2%
2025-08-08	459,715	8,051	1,864,876	24.7%
2025-08-07	128,993	0	477,471	27.0%
2025-08-06	135,353	0	270,326	50.1%
2025-08-05	155,507	0	306,008	50.8%
2025-08-04	538,789	0	695,296	77.5%
2025-08-01	219,930	2,347	388,852	56.6%
2025-07-31	184,381	200	390,483	47.2%
2025-07-30	95,394	0	227,715	41.9%
2025-07-29	57,767	0	242,031	23.9%
2025-07-28	80,537	10	232,823	34.6%
2025-07-25	113,424	112	240,376	47.2%
2025-07-24	72,275	63	219,301	33.0%
2025-07-23	136,784	0	320,495	42.7%
2025-07-22	223,486	1,552	478,272	46.7%
2025-07-21	163,879	0	341,514	48.0%
2025-07-18	97,369	0	250,155	38.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE